Russia labels GMOs, while America’s government sells out to the biotech poisoners and propagandists

Monday, March 25, 2019 by: Vicki Batts

(Natural News) GMO labeling laws have been a source of controversy in the United States for quite some time. Consumer advocates have called upon the federal government to protect Americans’ right to freedom of choice and to encourage transparency in the food industry, but officials seem to be more interested in defending corporate interests. Industry leaders are afraid proper GMO labeling will interfere with their bottom lines — that alone should be a huge red flag. But while federal officials in the United States are twiddling their thumbs over GMOs, nations around the world are beginning to take action. Russia, for example, just introduced clear GMO labeling on all foods.

While GMO labeling laws have been passed in the United States, the proposed implementation of such laws leaves much to be desired. Critics say GMO labeling practices enacted here in America function more like propaganda for the biotech industry. Brightly colored smiley-face stickers that don’t even bear the letters “GMO” are hardly a clear identifier, after all. Heaven forbid Americans actually make informed decisions about the food they eat– the entire industry would collapse overnight if people knew what they were really getting.

Clear GMO labeling comes to Russia

The Eurasian Economic Union (EAEU), which includes Russia, Kyrgyzstan, Kazakhstan, Armenia and Belarus, introduced their new, clear GMO labeling practices at the start of the new year. All food and supplements containing genetically modified ingredients will bear a “GMO” label on the packaging.

As Sustainable Pulse reports:

According to the new regulations, the basic size of the GMO label must not be less than 5 mm. The technical regulations also require that the GMO label be applied in a manner that provides easy readability and visibility throughout the shelf life of food and supplement products.

Across the board, the EAEU is taking a firm stance on GMOs. In 2016, Russia’s State Duma voted on a bill which would ban the cultivation of GMO crops and animals in Russia entirely, except for scientific purposes. And in 2018, the Kyrgyzstan government announced that it would be the second country in the world to adopt organic-only farming practices.

Unfortunately, the U.S. is a world away from reaching any kind of transparency on GMOs.

GMO labeling in the U.S. is lackluster

Congress passed a law to label GMO products in the U.S. back in 2016. Since that time, federal officials have been struggling to come up with the specifics of labeling such items. The USDA recently revealed a few of the “options” they’ve come up with. As NPR reports, all options are brightly colored, friendly looking labels that bear the letters “B.E” instead of “GMO.” Some show a smiling sun, or a circle of growing plants, too.

“B.E” is apparently supposed to stand for “bioengineered,” and this little change is clearly an attempt at placating Big Biotech and Big Ag. As critics have stated, replacing the well-known and easily recognizable term “GMO” arbitrarily with some new term will only confuse consumers. The average person may not be aware of the fact that “B.E” actually means “GMO.”

This is a blatant attempt to obscure truth and feign transparency, and it should not be tolerated. The federal government is literally conspiring to fool the American people, to protect corporate interests. Who are these federal agencies supposed to serve and protect, again?

George Kimbrell, the legal director for the Center for Food Safety, criticized the USDA’s iteration of GMO labeling. “They’re very pro-biotech, cartoonishly so, and to that extent are, you know, not just imparting information but instead are essentially propaganda for the industry,” he told NPR.

The failure to come up with a clear and easily understood label for GMO products is an affront to American freedom. Regardless of one’s view on GMOs, the simple fact remains that people have the right to choose what they put in their bodies. Ingredient labels exist for a reason — and GMO labels should, too. (Click to Source)

Learn about GMO labeling and more at GMO.news.

Sources for this article include:

SustainablePulse.com

NPR.org

Many of Big Pharma’s overpriced medications developed with taxpayer-funded research

american-flag-pills-medication-pharma-1

(Natural News) Big Pharma has been subject to immense scrutiny for quite some time now. Government inquiries of the industry date back to 1959, with Congress having launched over 50 individual hearings to investigate their practices. These hearings have reached the same conclusion: that Big Pharma is making huge profits at the expense of the American people. And yet, for some reason, the government has yet to do anything to put a stop to this nonsense.

In almost 60 years, since the investigations of Big Pharma began, Congress has never passed any kind of legislation to prevent the pharmaceutical industry from charging exorbitant prices — even for products that were developed with taxpayer dollars. (RELATED: Find out more about Big Pharma at Medicine.news)

Corporate greed keeps life-saving drugs from veterans

Just three years ago, in 2014, the Senate Subcommittee on Primary Health and Aging held a hearing to investigate the skyrocketing price of generic drugs. Drug prices have continued to increase since then, of course.

The following year, Gilead came under fire for their outlandish drug prices — most notably, the sky-high costs of their drugs for hepatitis C. One drug, Solvaldi, was actually developed by a research scientist from the Department of Veterans’ Affairs. After being acquired by Gilead, the product was priced so high that the VA — which paid to develop the drug — could not afford to give the pills to their own patients.

Gilead felt that it was fair for them to charge $1,000 per pill for a drug that they themselves had not even created. The retail price for a 12-week Solvaldi treatment is a sickening $84,000; even with a 50 percent discount, the VA was still unable to afford treatment for many sick veterans that contacted Hep C while overseas during the Vietnam War.

Only the lowest of the low could sleep at night, knowing that their price-gouging was preventing veterans from getting much-needed medical care.

Don’t worry, it gets worse.

Dr. Raymond Schinazi, the drug’s creator — owner of Pharmasett and at the time of the drug’s creation, Senior Research Scientist of the VA in Atlanta — admitted in a 2013 trade publication that an entire 12-week treatment of Solvaldi only cost $1,400 to make. A reportfrom Americans For Tax Fairness states that Schinazi and his private company received millions in federal grant money to conduct research and develop treatment for Hep C.

Schinazi sold his company to Gilead in 2012. Shortly after acquiring it, Gilead saw fit to raise the price of the drug — to nearly 60 times what it costs to produce.

Following their investigation of Gilead, government officials concluded that the only explanation for the explicit price-gouging was corporate greed: they charged as much as possible, purely because they could. (Click to Article)